Chemed Dividends and Buybacks
Dividend criteria checks 0/6
Chemed is a dividend paying company with a current yield of 0.54%.
Key information
0.5%
Dividend yield
4.8%
Buyback Yield
| Total Shareholder Yield | 5.4% |
| Future Dividend Yield | 0.5% |
| Dividend Growth | 7.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 10% |
Recent dividend and buyback updates
Recent updates
Chemed Corporation: Short-Term Headwinds But Long-Term Growth Potential
Jul 18Chemed Corporation (NYSE:CHE) Shares Could Be 23% Below Their Intrinsic Value Estimate
Jul 07
Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price
Jun 18Here's What Analysts Are Forecasting For Chemed Corporation (NYSE:CHE) After Its First-Quarter Results
May 01Why You Should Care About Chemed's (NYSE:CHE) Strong Returns On Capital
Apr 22Here's Why We Think Chemed (NYSE:CHE) Is Well Worth Watching
Apr 07Chemed Corporation's (NYSE:CHE) Intrinsic Value Is Potentially 61% Above Its Share Price
Mar 21Chemed Corporation's (NYSE:CHE) Popularity With Investors Is Clear
Mar 06Investors Shouldn't Overlook The Favourable Returns On Capital At Chemed (NYSE:CHE)
Jan 03With EPS Growth And More, Chemed (NYSE:CHE) Makes An Interesting Case
Dec 18Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 25% Undervaluation?
Dec 03The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Nov 01Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price
Oct 29
Strategic Acquisitions And Operational Efficiencies Set To Propel VITAS And Roto-Rooter Forward
Strategic acquisitions, such as Covenant Health, and aggressive hiring in VITAS are poised to enhance Chemed's revenue and net margins through improved operational efficiency.Chemed Remains A Buy On Long-Term Economics
Aug 16Chemed: Growth Does Not Justify The Current Stock Price
May 20Chemed: Continues To Compound Shareholder Value At Double-Digit Returns
Nov 30Stability and Growth of Payments
Fetching dividends data
Stable Dividend: CHE is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: CHE is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Chemed Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CHE) | 0.5% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.4% |
| Industry Average (Healthcare) | 2.1% |
| Analyst forecast (CHE) (up to 3 years) | 0.5% |
Notable Dividend: CHE's dividend (0.54%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.44%).
High Dividend: CHE's dividend (0.54%) is low compared to the top 25% of dividend payers in the US market (4.46%).
Earnings Payout to Shareholders
Earnings Coverage: CHE is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash Flow Coverage: CHE is not paying a notable dividend for the US market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 12:16 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Chemed Corporation is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Adam Feinstein | Barclays |
| Joanna Sylvia Gajuk | BofA Global Research |